Search

Your search keyword '"Maitland‐van der Zee, Anke H."' showing total 654 results

Search Constraints

Start Over You searched for: Author "Maitland‐van der Zee, Anke H." Remove constraint Author: "Maitland‐van der Zee, Anke H."
654 results on '"Maitland‐van der Zee, Anke H."'

Search Results

1. International Care programs for Pediatric Post-COVID Condition (Long COVID) and the way forward

3. Association between butyrate-producing gut bacteria and the risk of infectious disease hospitalisation: results from two observational, population-based microbiome studies

4. Whole blood transcriptome in long-COVID patients reveals association with lung function and immune response

6. Reframing sepsis immunobiology for translation: towards informative subtyping and targeted immunomodulatory therapies

7. Precision Medicine in Asthma Therapy

9. Cisplatin-induced nephrotoxicity in childhood cancer: comparison between two countries

10. Recent Advances in Systems and Network Medicine: Meeting Report from the First International Conference in Systems and Network Medicine

12. Long COVID exhibits clinically distinct phenotypes at 3–6 months post-SARS-CoV-2 infection: results from the P4O2 consortium

14. Real-World Effectiveness of Reslizumab in Patients With Severe Eosinophilic Asthma – First Initiators and Switchers

18. Precision Medicine in Asthma Therapy

23. Genetic variants associated with methotrexate-induced mucositis in cancer treatment: A systematic review and meta-analysis

24. Hemoglobin and Its Relationship with Fatigue in Long-COVID Patients Three to Six Months after SARS-CoV-2 Infection.

25. The effects of the COVID‐19 pandemic on PICU admissions for severe asthma exacerbations: A single‐center experience

26. A BEAT-PCD consensus statement: a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

27. Associations between spirometric impairments and microvascular complications in type 2 diabetes: a cross-sectional study

28. Genome-wide association study of angioedema induced by angiotensin-converting enzyme inhibitor and angiotensin receptor blocker treatment

29. Pharmacogenomic associations of adverse drug reactions in asthma: systematic review and research prioritisation

31. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials.

32. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study

33. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data.

35. Identification of long COVID phenotypes based on clinical presentation at 3 to 6 months post SARS-CoV-2 infection: results from the P4O2 consortium

36. Fatigue in post COVID-19 patients: the P4O2 COVID-19 study

38. Exploring the role of low-frequency and rare exonic variants in alcohol and tobacco use

40. Precision Medicine for More Oxygen (P4O2)—Study Design and First Results of the Long COVID-19 Extension

41. Neutrophil extracellular trap production and CCL4L2 expression influence corticosteroid response in asthma

42. Oropharyngeal Microbiota Clusters in Children with Asthma/Wheeze Associate with Allergy, Blood Transcriptomic Immune Pathways and Exacerbations Risk

43. Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

45. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study

46. International severe asthma registry (ISAR): protocol for a global registry

48. Haemophilus influenzae and Moraxella catarrhalis in sputum of severe asthma with inflammasome and neutrophil activation.

49. Association of Factor V Leiden With Subsequent Atherothrombotic Events: A GENIUS-CHD Study of Individual Participant Data

Catalog

Books, media, physical & digital resources